SEARCH

SEARCH BY CITATION

References

  • 1
    The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1989; 320: 9839.
  • 2
    Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345: 66981.
  • 3
    Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. AASLD practice guidelines. Hepatology 2007; 46: 92237.
  • 4
    Merkel C, Sacerdoti D, Finucci GF, et al. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. Br J Clin Pharmacol 1986; 21: 7139.
  • 5
    Ohnishi K, Nakayama T, Saito M, et al. Effects of propranolol on portal hemodynamics in patients with chronic liver disease. Am J Gastroenterol 1985; 80: 1325.
  • 6
    García-Pagán JC, Feu F, Bosch J, Rodés J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 1991; 114: 86973.
  • 7
    Cheung J, Wong W, Zandieh I, et al. Acute management and secondary prophylaxis of esophageal variceal bleeding: a Western Canadian survey. Can J Gastroenterol 2006; 20: 5314.
  • 8
    Zaman A, Hapke RJ, Flora K, Rosen HR, Benner KG. Changing compliance to the American college of gastroenterology guidelines for the management of variceal hemorrhage: a regional survey. Am J Gastroenterol 2004; 99: 6459.
    Direct Link:
  • 9
    Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001; 345: 64755.
  • 10
    Lo GH, Chen WC, Chen MH, et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002; 123: 72834.
  • 11
    Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002; 123: 10139.
  • 12
    Romero G, Kravetz D, Argonz J, et al. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther 2006; 24: 60111.
  • 13
    Sarin SK, Wadhawan M, Gupta R, Shahi H. Evaluation of endoscopic variceal ligation (EVL) versus propranolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and non-cirrhotic patients. Dig Dis Sci 2005; 50: 153847.
  • 14
    De Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 16776.
  • 15
    Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. AASLD practice guidelines. Am J Gastroenterol 2007; 102: 2086102.
    Direct Link:
  • 16
    Gonzalez R, Zamora J, Gomez-Camarero J, Molinero LM, Banares R, Albillos A. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 2008; 149: 10922.
  • 17
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 18
    Schulz KF. Subverting randomization in controlled trials. JAMA 1995; 274: 14568.
  • 19
    EggerM, SmithGD, AltmanDG, eds. Assessing the quality of randomized controlled trials. Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd edn. London: BMJ Publishing Group, 2001: 87104.
  • 20
    Gluud LL, Klingenberg S, Dimitrinka N, Gluud C. Band ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials. Am J Gastroenterol 2007; 102: 28428.
    Direct Link:
  • 21
    Marmo R. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. G Ital Endosc Dig 2002; 25: 10912.
  • 22
    Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mono-nitrates to prevent recurrent variceal bleeding. Gastrointest Endosc 2002; 55: 7614.
  • 23
    Wiest R, Lock G, Messmann H. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. Z Gastroenterol 2002; 40: 5479.
  • 24
    Aubert A, Meduri B, Fritsch J. Prevention of recurrent bleeding from esophageal varices by endoscopic ligation. Preliminary study. Gastroenterol Clin Biol 1993; 17: 4034.
  • 25
    Evrard S, Dumonceau JM, Delhaye M, Golstein P, Deviere J, Le Moine O. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy 2003; 35: 72935.
  • 26
    Parelon G, Guiry P, Daures JP, et al. Prevention of recurrent hemorrhage caused by the rupture of esophageal varices in cirrhotic patients. A controlled study of propranolol and clip ligation of the esophagus. Presse Med 1989; 18: 17437.
  • 27
    Jain A, Kumar A, Tyagi P, Sharma BC, Sarin SK. Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus endoscopic variceal ligation alone in secondary prophylaxis of variceal bleeding: a prospective randomized controlled trial [Abstract]. Am J Gastroenterol 2006; 101(Suppl 2): S179.
  • 28
    Gallego A, Villaneuva C, Ortiz J, et al. Preliminary results of a prospective and randomized trial comparing endoscopic ligation with nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding [Abstract]. Hepatology 1997; 26(Suppl 2): 1530.
  • 29
    Gallego A, Villanueva C, Ortiz J, et al. Endoscopic ligation compared with nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding. Preliminary results of a prospective and randomized trial [Abstract]. Gastrointest Endosc 1997; 45(Suppl S): 176.
  • 30
    Goulis J, Patch D, Greenslade L, Gerunda G, Merkel C, Burroughs AK. RCT of variceal ligation (VL) vs propranolol-iso-sorbide (PI) for variceal rebleeding with target pressure reduction: Methodological problems [Abstract]. Gut 1998; 42(Suppl 1): A19.
  • 31
    Minyana J, Gallego A, Vera JS, et al. Endoscopic ligation versus nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding. A prospective and randomized trial [Abstract]. Hepatology 1999; 30(Suppl S): 214A.
  • 32
    Romero G, Kravetz D, Argonz J, et al. Nadolol plus isosorbide mononitrate compared with banding plus low volume sclerotherapy for prevention of variceal rebleeding in patients with cirrhosis [Abstract]. Hepatology 2004; 40(Suppl 1): 204A.
  • 33
    De La Pena J, Rivero M, et al. Variceal ligation plus nadolol compared with variceal ligation after bleeding. Multicenter randomized trial. Preliminary analysis [Abstract]. Gastroenterology 2003; 124(Suppl S): A733.
  • 34
    Shiha G, Menesy A, Seef S, El Fakhry A, Khalek EA, Khalil N. Endoscopic ligation compared with propranolol and combined isosorbide mononitrate (ISMN) and propranolol to prevent recurrent variceal bleeding: A prospective randomized trial [Abstract]. Gut 2005; 54(Suppl 2): A6.
  • 35
    Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000; 32: 4615.
  • 36
    De La Pena J, Enric B, Sánchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005; 41: 5728.
  • 37
    Jha SK, Kumar A, Sharma BC, Sarin SK. Endoscopic variceal ligation (EVL) plus propranolol (P) and isosorbide mononitrate (ISMN) versus EVL alone in secondary prophylaxis of variceal bleeding: a prospective RCT [Abstract]. Hepatology 2007; 46(Suppl S): 250A1A.
  • 38
    Sollano JD, Chan MM, Ismael AE, Barbaran ROP, Lim EL. Propranolol prevents rebleeding after variceal ligation [Abstract]. Gastrointest Endosc 2001; 53(Suppl S): AB143.
  • 39
    Garcia-Pagan JC, Villanueva C, Alibillos A, et al. Nadolol + isosorbide-5-mononitrate (NAD+ISMN) vs. NAD+ISMN + endoscopic band ligation in the prevention of rebleeding in patients with cirrhosis. Preliminary results of a multicenter RCT [Abstract]. J Hepatol 2006; 44(Suppl 2): S11.
  • 40
    Lo GH, Chen MH, Lai KH. A randomized, controlled trial of banding ligation plus drug therapy vs drug therapy alone in the prevention of esophageal variceal rebleeding [Abstract]. Gut 2005; 54(Suppl 7): A78.
  • 41
    Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37: 9028.
  • 42
    Luca A, García-Pagán JC, Bosch J, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997; 112: 12849.